A
ETNB

AlphaQuest’s 89bio ETNB Stock Holding History

AlphaQuest’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5,956
Closed -$87.6K – 2265
2025
Q3 		$87.6K Sell
5,956
-658
-10% -$6.71K 0.01% 1777
2025
Q2 		$64.9K Buy
6,614
+4,506
+214% +$37.3K 0.01% 1559
2025
Q1 		$15.3K Buy
+2,108
New +$18.4K ﹤0.01% 1745
2024
Q4 		– Sell
-22,074
Closed -$163K – 1794
2024
Q3 		$163K Buy
22,074
+13,961
+172% +$117K 0.01% 1142
2024
Q2 		$65K Buy
8,113
+5,626
+226% +$50.2K 0.01% 1030
2024
Q1 		$28.9K Sell
2,487
-7,978
-76% -$88.3K 0.01% 993
2023
Q4 		$117K Buy
+10,465
New +$96.2K 0.02% 734

Other funds holding ETNB

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AlphaQuest's ETNB Position: Q4 2025 in Review

AlphaQuest sold out of 89bio (ETNB) in Q4 2025, closing a stake of 5,956 shares — an estimated $87.6K sold.

AlphaQuest first reported a position in ETNB in Q4 2023 and held it in 7 quarters. The position peaked at $163K in Q3 2024. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • AlphaQuest reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • AlphaQuest sold 5,956 89bio shares in Q4 2025, an estimated $87.6K.
  • AlphaQuest first reported a position in 89bio in Q4 2023 and held it in 7 quarters.
  • AlphaQuest's 89bio position peaked at $163K in Q3 2024.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on AlphaQuest's 13F filing for Q4 2025, filed 9 Feb 2026.